Aclaris Announces Pricing of Initial Public Offering
October 6, 2015

Celsus Therapeutics and Volution Immuno Pharmaceuticals Announce Completion of Acquisition and Formation of Complement C5 Inhibitor Company Akari Therapeutics Plc
September 18, 2015

Nabriva Therapeutics Prices Initial Public Offering
September 17, 2015

REGENXBIO Announces Pricing of Initial Public Offering
September 16, 2015

Trevena, Inc. Announces Closing of Public Offering of Common Stock
September 16, 2015

ProNAi Therapeutics Announces Pricing of Initial Public Offering
July 15, 2015

Biotie Announces Closing of U.S. Public Offering and Conversion of Convertible Notes
June 16, 2015

AirXpanders Announces Initial Public Offering in Australia
May 26, 2015

REGENXBIO Secures $70.5 Million in a Mezzanine Financing
May 20, 2015

Carbylan Therapeutics, Inc. Announces Pricing of Initial Public Offering
April 8, 2015

Nabriva Therapeutics Announces Financing of up to $120M to Advance Clinical Development of New Class of Antibiotic
April 7, 2015

Ascendis Pharma A/S Announces Pricing of Initial Public Offering
January 28, 2015

Ascendis Pharma A/S Completes $60 million Oversubscribed Series D Financing
December 1, 2014

Actavis to Acquire Durata Therapeutics, Inc.
October 6, 2014

FDA Approves Durata Therapeutics' DALVANCE™ for the Treatment of Acute Bacterial Skin and Skin Structure Infections (ABSSSI) Caused by Susceptible Gram-Positive Bacteria, Including MRSA, in Adults
May 23, 2014

ProNAi Therapeutics Raises $59.5 Million Series D Financing
April 21, 2014

The Medicines Company Acquires Rempex Pharmaceuticals
December 4, 2013

Ocera Therapeutics Announces $28 Million Private Placement
November 6, 2013

Actelion Closes Acquisition of Privately-Held Ceptaris Therapeutics Adding Valchlor to Actelion's Product Portfolio
September 19, 2013

Actelion enters into an agreement to acquire privately-held Ceptaris Therapeutics
July 31, 2013

Gilead Sciences to Acquire YM Biosciences
December 12, 2012

MEI Pharma Announces $27.5 Million Private Placement
November 5, 2012

Aclaris Formed to Develop Novel Dermatology Treatment; Raises $21 Million in Series A Financing
October 24, 2012

Bard Acquires Neomend, Inc.
October 23, 2012

Pfizer To Acquire NextWave Pharmaceuticals, Inc.
October 22, 2012

Medtronic Signs Agreement to Acquire China Kanghui Holdings
September 27, 2012

SentreHEART Secures $26 Million in Series C Financing for Commercialization
Redwood City, CA – June 4, 2012

Allergan, Inc. to Acquire Privately Held Dermatologic Company, Vicept Therapeutics
Malvern, PA & Irvine, CA - July 19, 2011

Sagent Pharmaceuticals Upsizes and Prices Initial Public Offering
Schaumburg, IL - April 20, 2011

AVANIR Pharmaceuticals Announces FDA Approval of NUEDEXTA™
Aliso Viejo, CA - October 29, 2010

OncoGenex Pharmaceuticals, Inc. Announces Proposed Public Offering
Bothell, WA & Vancouver - October 18, 2010

Yaupon Announces Positive Results from Pivotal Study of its Proprietary Topical Mechlorethamine Gel; A Potential Treatment for Early-Stage Cutaneous T-Cell Lymphoma
Radnor, PA - August 10, 2010

China Kanghui Holdings Announces Pricing of Initial Public Offering
Changzhou, China - August 10, 2010

United Therapeutics and Lee's Pharmaceutical Sign Remodulin Distribution Agreement for China
Silver Spring, MD - July 1, 2010

FDA Approves Sagent Pharmaceuticals, Inc.'s Heparin Sodium Injection, USP
Schaumburg, IL - July 1, 2010

Vicept Therapeutics Secures $10 Million to Complete Series A Funding; Company to Develop Lead Product for Rosacea and Other Topical Agents for the Treatment of Skin Disorders
Malvern, PA - June 30, 2010

Lee's Pharm Accredited "Asia's Best Companies 2010 - (China) Best Small Cap" Ranked 2nd
Hong Kong - June 8, 2010

Dynavax Raises $44 Million Through Public Offering of Common Stock and Warrants
Berkeley, CA - April 13, 2010

Sagent Pharmaceuticals Raises $40 Million in Two Tranches of a Series B Financing
Schaumburg, IL - April 8, 2010

Merz to Acquire BioForm Medical
Frankfurt, Germany & San Mateo, CA - January 4, 2010

Lee's Pharmaceutical Signed a Subscription Agreement with Vivo Ventures Fund
Shatin, Hong Kong - August 12, 2009

AVANIR Announces Positive Phase III Study Results for Zenvia
Aliso Viejo, CA - August 11, 2009

Eiger BioPharmaceuticals Announces Initiation of CLEAN-1 HCV Phase 1b Trial
Palo Alto, CA - August 10, 2009

KangHui Medical Raises Series B-1 Extension Round
Palo Alto, CA - April 24, 2009

Eiger BioPharmaceuticals Raises $7.1 Million 'A' Round
Palo Alto, CA - February 24, 2009

APT Pharmaceuticals Secures $32 Million in Series B Financing
Burlingame, CA - September 30, 2008

Sagent Completes $30 Million Series A Financing Extension
Schaumburg, IL - September 4, 2008

SpectraGenics Announces $30M in New Funding Changes Company Name to Tria Beauty
Pleasanton, CA - July 10, 2008

AVANIR to Raise $40.0 Million to Fund Zenvia Through Clinical Development and Regulatory Approval
Palo Alto, CA - Nov 26, 2007

Carbylan Announces $20 Million Series B Financing
Aliso Viejo, CA - March 27, 2008

Yaupon Therapeutics closes $14.5 million financing -- Series C financing positions company to advance development of its product portfolio targeting cancer and central nervous system diseases
Radnor, PA - Nov 26, 2007

BioForm Announces Pricing of Initial Public Offering
San Mateo, CA - Nov 07, 2007

APT Pharmaceuticals Closes New $22 Million Funding Round
Burlingame, CA - October 4, 2007

Sagent Pharmaceuticals Inc. Completes $53M Series A Financing
Schaumburg, IL - September 27, 2007

Acura Pharmaceuticals, Inc. secures financing to fund pivotal Phase III clinical trial for lead Aversion® technology product candidate
Palatine, IL - August 20, 2007

Capnia names chairman, CEO
Palo Alto, CA - August 6, 2007

Biodel Inc. Announces Completion of Public Offering
DANBURY, CT - May 17, 2007